Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin

被引:709
|
作者
Kenny-Walsh, E [1 ]
机构
[1] Cork Univ Hosp, Dept Med, Cork, Ireland
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 16期
关键词
D O I
10.1056/NEJM199904223401602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Methods In February 1994, batches of anti-D immune globulin used in Ireland during 1977 and 1978 to prevent Rh isoimmunization were found to be contaminated with hepatitis C virus (HCV) from a single infected donor. In March 1994, a national screening program was initiated for all women who had received anti-D immune globulin between 1970 and 1994. Of the 62,667 women who had been screened when this study began, 704 (1.1 percent) had evidence of past or current HCV infection, and 390 of those 704 (55 percent) had positive tests for serum HCV RNA on reverse-transcription-polymerase-chain-reaction analysis. All 390 Were offered a referral for clinical assessment and therapy. We evaluated 376 of these 390 women (96 percent); the other 14 were not seen at one of the designated treatment centers. Results The mean (+/-SD) age of the 376 women was 45+/-6 years at the time of screening. They had been infected with hepatitis C for about 17 years. A total of 304 women (81 percent) reported symptoms, most commonly fatigue (248 women [66 percent]). Serum alanine aminotransferase concentrations were slightly elevated (40 to 99 U per liter) in 176 of 371 women (47 percent), and the concentrations were 100 U per liter or higher in 31 (8 percent). Liver biopsies showed inflammation in 356 of 363 women (98 percent); in most cases the inflammation was slight (41 percent) or moderate (52 percent). Although the biopsy samples from 186 of the 363 women (51 percent) showed evidence of fibrosis, only 7 women (2 percent) had probable or definite cirrhosis. Two of the seven reported excessive alcohol consumption. Conclusions Most of the women with HCV infection 17 years after receiving HCV-contaminated anti-D immune globulin had evidence of slight or moderate hepatic inflammation on liver biopsy, about half had fibrosis, and 2 percent had probable or definite cirrhosis, (N Engl J Med 1999;340:1228-33.) (C) 1999, Massachusetts Medical Society.
引用
收藏
页码:1228 / 1233
页数:6
相关论文
共 50 条
  • [41] Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects
    Long, Michelle
    Kalish, Leslie A.
    Neufeld, Ellis J.
    Grace, Rachael F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 315 - 317
  • [42] LACK OF CLINICAL AND IMMUNOLOGICAL EVIDENCE OF AUTOIMMUNE-DISEASE IN ANTI-D ASSOCIATED HEPATITIS-C VIRUS-INFECTION
    SACHITHANANDAN, S
    ALBLOUSHI, S
    HOLLOWAY, H
    COURTNEY, MG
    FIELDING, JF
    GASTROENTEROLOGY, 1995, 108 (04) : A908 - A908
  • [43] Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
    Trebo, Monika M.
    Frey, Eva
    Gadner, Helmut
    Minkov, Milen
    ANNALS OF HEMATOLOGY, 2010, 89 (04) : 415 - 418
  • [44] Cost of treating patients with immune thrombocytopenic purpura with anti-D immune globulin and intravenous immune globulin: a retrospective database analysis of outpatient claims
    Bonnet, P. O.
    Dobler, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 557 - 557
  • [45] Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura
    Deborah Kees-Folts
    Arthur B. Abt
    Ronald E. Domen
    Andrew S. Freiberg
    Pediatric Nephrology, 2002, 17 : 91 - 96
  • [46] Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura
    Kees-Folts, D
    Abt, AB
    Domen, RE
    Freiberg, AS
    PEDIATRIC NEPHROLOGY, 2002, 17 (02) : 91 - 96
  • [47] Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland
    Albloushi, SS
    Murray, FE
    Callagy, G
    Courtney, MG
    O'Keane, JC
    Kay, E
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (01) : 69 - 73
  • [48] Cost-minimization analysis of anti-D immune globulin versus intravenous immune globulin for the initial treatment of immune thrombocytopenic purpura.
    Wetzel, David A.
    Tarantino, Michael D.
    BLOOD, 2006, 108 (11) : 943A - 943A
  • [49] Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study
    Eghbali, Aziz
    Azadmanesh, Peyman
    Bagheri, Bahador
    Taherahmadi, Hasan
    Sedeh, Bahman Sadeghi
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (04) : 385 - 389
  • [50] RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia
    Despotovic, Jenny M.
    McGann, Patrick T.
    Smeltzer, Matthew
    Aygun, Banu
    Ware, Russell E.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E106 - E108